Celera and other defendants have entered into a memorandum of understanding in putative class action lawsuits stemming from the company's proposed acquisition by Quest Diagnostics.
LabCorp completed its $107 million purchase of Monogram this week.
Newsweek discusses the privacy issues raised by digital medicine.
A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.
In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.
A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.